Hyperprogression of a Sinonasal Squamous Cell Carcinoma Following Programmed Cell Death Protein-1 Checkpoint Blockade

Said Izreig; Faisal Alzahrani; Joseph Earles; Saral Mehra; Benjamin L. Judson; Zenggang Pan; Rahmatullah W. Rahmati

doi:10.1001/jamaoto.2020.2584

Back

Hyperprogression of a Sinonasal Squamous Cell Carcinoma Following Programmed Cell Death Protein-1 Checkpoint Blockade

Journal article

Peer reviewed

Hyperprogression of a Sinonasal Squamous Cell Carcinoma Following Programmed Cell Death Protein-1 Checkpoint Blockade

Said Izreig, Faisal Alzahrani, Joseph Earles, Saral Mehra, Benjamin L. Judson, Zenggang Pan and Rahmatullah W. Rahmati

JAMA otolaryngology-- head & neck surgery, Vol.146(12), pp.1176-1178

01/12/2020

DOI: https://doi.org/10.1001/jamaoto.2020.2584

PMID: 32940637

Abstract

Life Sciences & Biomedicine

Otorhinolaryngology

Science & Technology

Surgery

This case report describes man in his 60s who presented with a maxillary sinus squamous cell carcinoma and experienced hyperprogression following treatment with pembrolizumab.

Metrics

1 Record Views

See more details

Details

Title: Hyperprogression of a Sinonasal Squamous Cell Carcinoma Following Programmed Cell Death Protein-1 Checkpoint Blockade
Creators - without role: Said Izreig - Yale University
Faisal Alzahrani - Yale University
Joseph Earles - Yale University
Saral Mehra - Yale University
Benjamin L. Judson - Yale University
Zenggang Pan - Yale University
Rahmatullah W. Rahmati - Yale University
Publication Details: JAMA otolaryngology-- head & neck surgery, Vol.146(12), pp.1176-1178
Publisher: Amer Medical Assoc
Number of pages: 3
Identifiers: 9920773808331
Academic Unit: King Abdulaziz University
Language: English
Resource Type: Journal article